PF-Atlas › Clinical Trials › NCT00631839
Prospective Study on Factors Predicting Chemo-Radiotherapy Induced Pulmonary and Esophageal Injury
Thoracic 3-D Conformal Radiotherapy · Not specified
Registry ID
NCT00631839
Phase
Not specified
Status
Unknown
Drug / intervention
Thoracic 3-D Conformal Radiotherapy
Sponsor
Shanghai Cancer Hospital, China
Start
2002-01
Enrollment
140
Locations
1
About this trial
The purpose of this study is to evaluate clinical, dosimetrical, functional, biological and genetic factors in predicting chemo-radiotherapy induced lung and esophagus injury.
Explore related
Medical disclaimer. This page summarizes public trial data for NCT00631839 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.